A study revealed that parents of children with atopic dermatitis experience less than optimal sleep and are more reliant on ...
Current dermatological guidelines now recognize crisaborole two percent ointment as a potential first-line treatment option ...
Corvus Pharmaceuticals' stock plummeted ~40% after Phase 1 data for soquelitinib in AD showed mixed results. See why I ...
Self-guided cognitive behavioral therapy (CBT) proved noninferior to clinician-guided CBT for reducing symptom severity in ...
The US Food and Drug Administration (FDA) has approved Organon’s Vtama (tapinarof) cream, 1% to treat atopic dermatitis in ...
AnaptysBio's rosnilimab faces significant competition and uncertainty. See why ANAB stock's future hinges on Feb 2025 Phase ...
The US Food and Drug Administration (FDA) has approved Vtama (tapinarof) cream 1%, an aryl hydrocarbon receptor agonist, for ...
The 2024 American Academy of Dermatology conference was held in San Diego, California March 8 to 11.
Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis ...
12d
Pets Radar on MSNSkin conditions in dogs: Symptoms, causes, and how to helpParasites, including fleas and mites, are a common cause of skin disease in dogs, according to Dr. MacMillan. If your dog is ...
FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older ...
For some people, keeping up with eczema treatments can be difficult, but resources are available to help find relief from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results